Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

Moussab Damlaj, MD, Mohsen Al-Zahrani, MD, Ghulam Syed, MD, Giamal Gmati, MD, Tabrez Pasha, Khadega Abuelgasim, MD, Bader Alahmari, MD, Ayman Alhejazi, MD, Ahmed Alaskar, MD FRCPC

Blood (2017) 130 (Supplement 1): 2799.

https://doi.org/10.1182/blood.V130.Suppl_1.2799.2799

Published: 2017

Journal Articles

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

Frank G Keller, MD, James Nachman, MD, Louis Constine, MD, John Thomson, MD, Kathleen M McCarten, MD, Lu Chen, PhD, Cindy Schwartz, MD

Blood (2010) 116 (21): 767.

https://doi.org/10.1182/blood.V116.21.767.767

Published: 2010

Journal Articles

Intensified CHOP (ICHOP) +/− Rituximab in Primary Mediastinal Diffuse Large B Cell Lymphoma (PMBCL): The Role of Doxorubicin/Cyclophosphamide Dose-Intensity

Rita Mazza, MD, Monica Demarco, MD, Michele Spina, MD, Massimo Magagnoli, MD, Luca Castagna, MD, Licia Siracusano, MD, Laura Giordano, PhD, Umberto Tirelli, MD, Armando Santoro, MD, Monica Balzarotti, MD

Blood (2008) 112 (11): 3593.

https://doi.org/10.1182/blood.V112.11.3593.3593

Published: 2008

Journal Articles

Low Predictive Value of Functional Imaging with 18 FDG-PET or Gallium Scanning in Relapsed or Refractory Hodgkin Lymphoma Prior to Autologous Stem Cell Transplantation.

Stefan Peinert, MD, Rosemary Hoyt, MD, Jeff Szer, MD, Andrew Roberts, MD, Andrew Grigg, MD, H. Miles Prince, MD, Luigi Rigacci, MD, John F. Seymour, MD, David S. Ritchie, MD

Blood (2007) 110 (11): 5127.

https://doi.org/10.1182/blood.V110.11.5127.5127

Published: 2007

Journal Articles

Front-Line Consolidation with Autologous Stem Cell Transplantation in Patients with Nodal Aggressive Peripheral T-Cell Lymphoma (PTCL). A Prospective Study of the GEL-TAMO.

Jose Rodriguez, MD, Eulogio Conde, MD, Antonio Gutierrez, MD, Reyes Arranz, MD, Angel Leon, MD, Julian Marin, MD, Maurizio Bendandi, MD, Carmen Albo, MD, Maria Dolores Caballero, MD

Blood (2006) 108 (11): 2463.

https://doi.org/10.1182/blood.V108.11.2463.2463

Published: 2006

Journal Articles

Computed Tomography (CT) Scan Response Stability and Gallium Scan Evaluation as On-Treatment Prognostic Parameters To Tailor Treatment Intensity of Newly Diagnosed Hodgkin’s Lymphoma (HL). A Prospective Phase II Study.

Alessandro Re, MD, Samantha Ferrari, MD, Paolo Frata, MD, Claudio Pizzocaro, MD, Fabio Franco, MD, Valentina Rossi, MD, AnnaMaria Pelizzari, MD, Claudia Crippa, MD, Nicoletta Petrella, MD, Alessandra Tucci, MD, Fabio Facchetti, MD, PhD, Luigi Grazioli, MD, Stefano Magrini, MD, PhD, Giuseppe Rossi, MD

Blood (2005) 106 (11): 2669.

https://doi.org/10.1182/blood.V106.11.2669.2669

Published: 2005

Journal Articles

Has the 67 Ga-SPET a Role in Monitoring Hodgkin and Primary Mediastinal Lymphoma in the PET-FDG Age?.

Isabella Palumbo, Giorgia Desantis, Barbara Palumbo, Lorenzo Falchi, Paola Cerroni, Vincenzo Capparella, Michele Cianciulli, Renato Palumbo, Anna M. Liberati

Blood (2005) 106 (11): 4643.

https://doi.org/10.1182/blood.V106.11.4643.4643

Published: 2005

Journal Articles

R-CHOP in the Treatment of DLBCL: Single Institution Experience from North India.

Ashok K. Vaid, DM, Sachin Gupta, DNB, Dinesh C. Doval, Vineet Talwar, Rajeev Gupta, J. B. Sharma, A. K. Chaturvedi, Neeraj Prakesh

Blood (2005) 106 (11): 4773.

https://doi.org/10.1182/blood.V106.11.4773.4773

Published: 2005

Journal Articles

Predictive Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Performed after Two Cycles of Standard Chemotherapy (CT) on Treatment Outcome in Hodgkin Disease.

Andrea Gallamini, MD, Luigi Rigacci, MD, Francesco Merli, MD, Pasquale Errico, MD, Alessandro Levis, MD, Alberto Biggi, MD, Antonio Castagnoli, MD, Silvia Tavera, MD, Luca Nassi, MD

Blood (2004) 104 (11): 310.

https://doi.org/10.1182/blood.V104.11.310.310

Published: 2004

Journal Articles

Primary Mediastinal Large B Cell Lymphoma: Elucidating Optimal Therapy and Prognostic Factors; an Analysis in 141 Consecutive Patients Treated at Memorial Sloan Kettering from 1980–1999.

Paul A. Hamlin, MD, Carol S. Portlock, MD, David J. Straus, MD, Ariela Noy, MD, Steven M. Horwitz, MD, Owen O’Connor, MD, PhD, Joachim Yahalom, MD, Andrew D. Zelenetz, MD, PhD, Craig H. Moskowitz, MD

Blood (2004) 104 (11): 614.

https://doi.org/10.1182/blood.V104.11.614.614

Published: 2004

Journal Articles

Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67 Gallium Scan in 50 Patients

Pier Luigi Zinzani, Maurizio Martelli, Massimo Magagnoli, Edoardo Pescarmona, Laura Scaramucci, Francesca Palombi, Maurizio Bendandi, Maria Paola Martelli, Stefano Ascani, Giulio Fraternali Orcioni, Stefano A. Pileri, Franco Mandelli, Sante Tura

Blood (1999) 94 (10): 3289–3293.

https://doi.org/10.1182/blood.V94.10.3289.422k32_3289_3293

Published: 1999

NARROW

Escalation from ABVD Following Positive Interim Functional Imaging Improves Progression Free Survival but Not Overall Survival in Advanced Classical Hodgkin Lymphoma - a Real World Analysis

A Phase III Study for the Treatment of Children and Adolescents with Newly Diagnosed Low Risk Hodgkin Lymphoma (HL)

Intensified CHOP (ICHOP) +/− Rituximab in Primary Mediastinal Diffuse Large B Cell Lymphoma (PMBCL): The Role of Doxorubicin/Cyclophosphamide Dose-Intensity

Low Predictive Value of Functional Imaging with 18 FDG-PET or Gallium Scanning in Relapsed or Refractory Hodgkin Lymphoma Prior to Autologous Stem Cell Transplantation.

Front-Line Consolidation with Autologous Stem Cell Transplantation in Patients with Nodal Aggressive Peripheral T-Cell Lymphoma (PTCL). A Prospective Study of the GEL-TAMO.

Computed Tomography (CT) Scan Response Stability and Gallium Scan Evaluation as On-Treatment Prognostic Parameters To Tailor Treatment Intensity of Newly Diagnosed Hodgkin’s Lymphoma (HL). A Prospective Phase II Study.

Has the 67 Ga-SPET a Role in Monitoring Hodgkin and Primary Mediastinal Lymphoma in the PET-FDG Age?.

R-CHOP in the Treatment of DLBCL: Single Institution Experience from North India.

Predictive Value of 18 F-Fluorodeoxyglucose Positron Emission Tomography (FDG PET) Performed after Two Cycles of Standard Chemotherapy (CT) on Treatment Outcome in Hodgkin Disease.

Primary Mediastinal Large B Cell Lymphoma: Elucidating Optimal Therapy and Prognostic Factors; an Analysis in 141 Consecutive Patients Treated at Memorial Sloan Kettering from 1980–1999.

Treatment and Clinical Management of Primary Mediastinal Large B-Cell Lymphoma With Sclerosis: MACOP-B Regimen and Mediastinal Radiotherapy Monitored by 67 Gallium Scan in 50 Patients

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only